A new approach for leptomeningeal metastases: chemotherapy administered through lumbar intrathecal port.

The LIP system, which has been used for intrathecal pain management for decades, appears to offer a safe alternative for intrathecal chemotherapy in patients with leptomeningeal metastases. Further studies are warranted to clarify its potential use in this setting.